Does CISPLATIN Cause Diffuse large b-cell lymphoma refractory? 156 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 156 reports of Diffuse large b-cell lymphoma refractory have been filed in association with CISPLATIN (CISplatin). This represents 0.3% of all adverse event reports for CISPLATIN.
156
Reports of Diffuse large b-cell lymphoma refractory with CISPLATIN
0.3%
of all CISPLATIN reports
25
Deaths
42
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma refractory From CISPLATIN?
Of the 156 reports, 25 (16.0%) resulted in death, 42 (26.9%) required hospitalization, and 6 (3.8%) were considered life-threatening.
Is Diffuse large b-cell lymphoma refractory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CISPLATIN. However, 156 reports have been filed with the FAERS database.
What Other Side Effects Does CISPLATIN Cause?
Off label use (4,359)
Disease progression (3,746)
Neutropenia (3,095)
Febrile neutropenia (3,010)
Nausea (2,923)
Drug ineffective (2,608)
Thrombocytopenia (2,565)
Anaemia (2,530)
Vomiting (2,326)
Diarrhoea (2,022)
What Other Drugs Cause Diffuse large b-cell lymphoma refractory?
RITUXIMAB (461)
CYCLOPHOSPHAMIDE (360)
DOXORUBICIN (345)
VINCRISTINE (331)
ETOPOSIDE (244)
PREDNISONE (214)
EPCORITAMAB-BYSP (198)
CYTARABINE (193)
DEXAMETHASONE (170)
IFOSFAMIDE (154)
Which CISPLATIN Alternatives Have Lower Diffuse large b-cell lymphoma refractory Risk?
CISPLATIN vs CISPLATIN\CYTARABINE\DEXAMETHASONE
CISPLATIN vs CITALOPRAM
CISPLATIN vs CITALOPRAM HYDROBROMIDE
CISPLATIN vs CITALOPRAM\CITALOPRAM HYDROBROMIDE
CISPLATIN vs CITICOLINE